BACKGROUND Tumor response to neoadjuvant chemotherapy using the regimen of
cisplatin and 5‐fluorouracil could define high‐risk patients with locoregionally advanced …

The purpose of this study was to create a prognostic model for distant metastasis in patients
with locally advanced NPC who accept concurrent chemotherapy combined with intensity …

Background The role of neoadjuvant chemotherapy (NACT) for locoregionally advanced
nasopharyngeal carcinoma (NPC) is unclear. We aimed to evaluate the feasibility and …

Background In the era of intensity‐modulated radiotherapy (IMRT), the role of neoadjuvant
chemotherapy (NAC) for locoregionally advanced nasopharyngeal carcinoma (NPC) is …

Aim of the study Previous results from our trial showed that adjuvant cisplatin and
fluorouracil chemotherapy did not significantly improve survival after concurrent …

Objective To determine whether concurrent chemoradiotherapy (CCRT) can improve
survival rates compared to the neoadjuvant chemotherapy (NACT) regimen in locoregionally …

BACKGROUND The authors studied the efficacy of neoadjuvant chemotherapy, consisting
of a taxane, cisplatin, and 5‐fluorouracil (5‐FU)(the TPF regimen) followed by concurrent …

BACKGROUND Promising results from a Phase II trial of induction chemotherapy and
sequential radiotherapy for advanced nasopharyngeal carcinoma (NPC) at The University of …

BACKGROUND: The current standard treatment for locoregionally advanced
nasopharyngeal carcinoma (NPC) was conventional–fractionation radiotherapy plus …

Background Concurrent chemoradiotherapy followed by adjuvant chemotherapy (CCRT-
AC) is currently recommended as the standard treatment for locally advanced …